1. Novel Central Nervous System (CNS)-targeting Protease Inhibitors for Drug-resistant HIV Infection and HIV-associated CNS Complications. Amano, M., P.M. Salcedo-Gomez, R.S. Yedidi, R. Zhao, H. Hayashi, K. Hasegawa, T. Nakamura, C.D. Martyr, A.K. Ghosh, and H. Mitsuya. Antimicrobial Agents and Chemotherapy, 2019. 63(7): e00466-00419. PMID[31061155].
[PubMed]. HIV_06_2019.
2. Carboxylate-functionalized Foldamer Inhibitors of HIV-1 Integrase and Topoisomerase 1: Artificial Analogues of DNA Mimic Proteins. Corvaglia, V., D. Carbajo, P. Prabhakaran, K. Ziach, P.K. Mandal, V.D. Santos, C. Legeay, R. Vogel, V. Parissi, P. Pourquier, and I. Huc. Nucleic Acids Research, 2019. 47(11): p. 5511-5521. PMID[31073604]. PMCID[PMC6582331].
[PubMed]. HIV_06_2019.
3. In Vitro Antimalarial, Antitrypanosomal and HIV-1 Integrase Inhibitory Activities of Two Cameroonian Medicinal Plants: Antrocaryon klaineanum (Anacardiaceae) and Diospyros conocarpa (Ebenaceae). Fouokeng, Y., H.M.F. Feusso, J.E.M. Teinkela, X.S. Noundou, R. Wintjens, M. Isaacs, H.C. Hoppe, R.W.M. Krause, A.G.B. Azebaze, and J.C. Vardamides. South African Journal of Botany, 2019. 122: p. 510-517. ISI[000469020300035].
[WOS]. HIV_06_2019.
4. Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-type HIV-1 and Multi-PI-resistant Variants. Hattori, S., H. Hayashi, H. Bulut, K.V. Rao, P.R. Nyalapatla, K. Hasegawa, M. Aoki, A.K. Ghosh, and H. Mitsuya. Antimicrobial Agents and Chemotherapy, 2019. 63(6): e02635-02618. PMID[30962341]. PMCID[PMC6535520].
[PubMed]. HIV_06_2019.
5. IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation. Hotter, D., M. Bosso, K.L. Jonsson, C. Krapp, C.M. Sturzel, A. Das, E. Littwitz-Salomon, B. Berkhout, A. Russ, S. Wittmann, T. Gramberg, Y. Zheng, L.J. Martins, V. Planelles, M.R. Jakobsen, B.H. Hahn, U. Dittmer, D. Sauter, and F. Kirchhoff. Cell Host & Microbe, 2019. 25(6): p. 858-872. PMID[31175045].
[PubMed]. HIV_06_2019.
6. Synthesis of Distal and Proximal Fleximer Base Analogues and Evaluation in the Nucleocapsid Protein of HIV-1. Ku, T., N. Lopresti, M. Shirley, M. Mori, J. Marchant, X. Heng, M. Botta, M.F. Summers, and K.L. Seley-Radtke. Bioorganic & Medicinal Chemistry, 2019. 27(13): p. 2883-2892. ISI[000470106900016].
[WOS]. HIV_06_2019.
7. Targeting HIV-TB Coinfection by Developing Novel Piperidin-4-substituted Imines: Design, Synthesis, in Vitro and in Silico Studies. Kumar, A., R. Revathi, D. Sriram, F. Curreli, A.K. Debnath, K.S. Pai, and S.G. Kini. Archiv der Pharmazie, 2019. 352(6): e1800358. PMID[31066103].
[PubMed]. HIV_06_2019.
8. A Novel Bromodomain Inhibitor, CPI-203, Serves as an HIV-1 Latency-reversing Agent by Activating Positive Transcription Elongation Factor B. Liang, T., X. Zhang, F. Lai, J. Lin, C. Zhou, X. Xu, X. Tan, S. Liu, and L. Li. Biochemical Pharmacology, 2019. 164: p. 237-251. PMID[30991051].
[PubMed]. HIV_06_2019.
9. Synthesis, Structural Characterization, EPR Spectroscopy and Hirshfeld Surface Analysis of a Novel Cu(2+)-Doped 3,14-Diethyl-2,13-diaza-6,17-diazoniatricyclo[16.4.0.0(7,12)]docosane bis(perchlorate). Moncol, J., M. Mazur, M. Valko, and J.H. Choi. Acta Crystallographica. Section C, Structural Chemistry, 2019. 75(Pt 6): p. 616-622. PMID[31166912].
[PubMed]. HIV_06_2019.
10. Structural Studies of Antiviral Inhibitor with HIV-1 Protease Bearing Drug Resistant Substitutions of V32I, I47V and V82I. Pawar, S., Y.F. Wang, A. Wong-Sam, J. Agniswamy, A.K. Ghosh, R.W. Harrison, and I.T. Weber. Biochemical and Biophysical Research Communications, 2019. 514(3): p. 974-978. PMID[31092330]. PMCID[PMC6601333].
[PubMed]. HIV_06_2019.
11. Design, Synthesis and Evaluation of Thiourea Derivatives as Antimicrobial and Antiviral Agents. Ravichandran, V., S. Shalini, K.S. Kumar, H. Rajak, and R.K. Agrawal. Letters in Drug Design & Discovery, 2019. 16(6): p. 618-624. ISI[000468954500002].
[WOS]. HIV_06_2019.
12. Oxazole-benzenesulfonamide Derivatives Inhibit HIV-1 Reverse Transcriptase Interaction with Cellular eEF1a and Reduce Viral Replication. Rawle, D.J., D. Li, Z. Wu, L. Wang, M. Choong, M. Lor, R.C. Reid, D.P. Fairlie, J. Harris, G. Tachedjian, S.A. Poulsen, and D. Harrich. Journal of Virology, 2019. 93(12): e00239-00219. PMID[30918071].
[PubMed]. HIV_06_2019.
13. Dual HIV-1 Reverse transcriptase and Integrase Inhibitors from Limonium morisianum Arrigoni, an Endemic Species of Sardinia (Italy). Sanna, C., D. Rigano, A. Corona, D. Piano, C. Formisano, D. Farci, G. Franzini, M. Ballero, G. Chianese, E. Tramontano, O. Taglialatela-Scafati, and F. Esposito. Natural Product Research, 2019. 33(12): p. 1798-1803. PMID[29397771].
[PubMed]. HIV_06_2019.
14. Dual Activity of Amphiphilic Zn(II) Nitroporphyrin Derivatives as HIV-1 Entry Inhibitors and in Cancer Photodynamic Therapy. Sengupta, D., U. Timilsina, Z.H. Mazumder, A. Mukherjee, D. Ghimire, M. Markandey, K. Upadhyaya, D. Sharma, N. Mishra, T. Jha, S. Basu, and R. Gaur. European Journal of Medicinal Chemistry, 2019. 174: p. 66-75. PMID[31029945].
[PubMed]. HIV_06_2019.
15. Biological Activity of Plant Extracts and Isolated Compounds from Alchornea laxiflora: Anti-HIV, Antibacterial and Cytotoxicity Evaluation. Siwe-Noundou, X., D.T. Ndinteh, D.K. Olivier, D. Mnkandhla, M. Isaacs, F.M. Muganza, J.T. Mbafor, S.F. Van Vuuren, S. Patnala, H. Hoppe, and R.W.M. Krause. South African Journal of Botany, 2019. 122: p. 498-503. ISI[000469020300033].
[WOS]. HIV_06_2019.
16. Penicillixanthone A, a Marine-derived Dual-coreceptor Antagonist as anti-HIV-1 Agent. Tan, S.Y., B. Yang, J. Liu, T.R. Xun, Y.H. Liu, and X.F. Zhou. Natural Product Research, 2019. 33(10): p. 1467-1471. PMID[29258357].
[PubMed]. HIV_06_2019.
Patent Citations
17. Carbocyclic Nucleoside Reverse transcriptase Inhibitors as HIV Treatment and Their Preparation. Alexandre, F.-R., R. Rahali, I. Raheem, and C. Parsy. Patent. 2019. 2018-16212121 20190177326: 46pp.
[Patent]. HIV_06_2019.